We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

Latest Whitepapers

The Battle Against COVID-19
Whitepaper

The Battle Against COVID-19

The battle against COVID-19 only begins with a test to identify who is infected and who is not. To accelerate an effective response, we have to move beyond the initial diagnosis to prognosis: Who is most susceptible to developing serious, life-threatening symptoms?
The Battle Against COVID-19
Whitepaper

The Battle Against COVID-19

The battle against COVID-19 only begins with a test to identify who is infected and who is not. To accelerate an effective response, we have to move beyond the initial diagnosis to prognosis: Who is most susceptible to developing serious, life-threatening symptoms?
COVID-19 and Organoids: Mini Organs With Massive Potential
Whitepaper

COVID-19 and Organoids: Mini Organs With Massive Potential

Download your whitepaper to learn more about modeling COVID-19 infection in organoids, how to combat COVID-19 variants as well as the future of organoid technology.
Considerations for Efficient Scale-Up of PSCs in Suspension Culture
Whitepaper

Considerations for Efficient Scale-Up of PSCs in Suspension Culture

Download this whitepaper to discover scale-up considerations such as suspension culture passaging strategies, medium exchange strategies plus suspension culture seeding density.
Aberrant Cytokine Activity in the Host Immune Response to COVID-19 Leads to Cytokine Release Syndrome
Whitepaper

Aberrant Cytokine Activity in the Host Immune Response to COVID-19 Leads to Cytokine Release Syndrome

Since the first cases of COVID-19 were identified in December 2019, the disease has spread across the world, claiming over half a million lives and affecting millions of others.
Autologous CAR T-Cell Manufacturing
Whitepaper

Autologous CAR T-Cell Manufacturing

Cell-based chimeric antigen receptor (CAR) T-cell therapies have rapidly advanced from preclinical research. This success has driven an influx of companies to further develop CAR T-cell constructs to make them more effective, safe and persistent.
Challenging Host Cell Protein Assays for Improved Risk Mitigation
Whitepaper

Challenging Host Cell Protein Assays for Improved Risk Mitigation

Host Cell Proteins (HCPs) are a heterogeneous, complex group of proteins that derived from the host cell. Regulatory agencies examine each protein drug on a case-by-case basis to determine appropriate maximum acceptable levels of HCPs considering patient risk.
Reliable Results from Cell-Based Bioassays
Whitepaper

Reliable Results from Cell-Based Bioassays

While common laboratory plastics are generally regarded as inert by researchers, some commonly used products such as pipette tips and sample tubes have been reported to leach chemical compounds including oleamide, erucamide and DiHEMDA.
Pharma Efficiencies, Data Compliance and Weighing Excellence
Whitepaper

Pharma Efficiencies, Data Compliance and Weighing Excellence

With time a precious commodity and ever-increasing regulatory scrutiny, pharmaceutical laboratories are always on the lookout for simple solutions to make their routine tasks easier.
What Is Your CO<sub>2</sub> Incubator Telling You?
Whitepaper

What Is Your CO2 Incubator Telling You?

Download this whitepaper to learn more about the three types of incubator monitoring, the level of data and visibility your incubator provides as well as monitoring physiological pH.
Advertisement